NCT01010490

Brief Summary

To determine the differences in intra-operative complications, surgical duration, fluid usage, corneal thickness and endothelium cell density in eyes undergoing microcoaxial phacoemulsification (MCP) either with Torsional or longitudinal ultrasound during the surgery and at post-operative day 1, 1 month and 3 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
360

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started May 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2009

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 9, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 10, 2009

Completed
Last Updated

November 13, 2009

Status Verified

November 1, 2009

Enrollment Period

1.6 years

First QC Date

November 9, 2009

Last Update Submit

November 11, 2009

Conditions

Keywords

PACHYMETRYCELL LOSSSAFETYEFFICACYPHACOEMULSIFICATIONIntraoperative complicationsCLOCK TIMEFLUID USEDCORNEAL THICKNESSENDOTHELIUM CELL LOSS

Outcome Measures

Primary Outcomes (1)

  • Intra-operative complications, surgical clock time in minutes (SCT), fluid volume in ml(FV), and central corneal thickness in µm (CCT) on day 1 and months 1 and 3, and endothelial cell density (ECD) at 3 months.

    3 months post-operative

Study Arms (3)

Torsional ultrasound

EXPERIMENTAL

Torsional ultrasound with the INFINITI phacoemulsification system (Alcon Lab, USA)

Procedure: Torsional ultrasound (INFINITI, Alcon, USA)

Longitudinal ultrasound (INFINITI)

ACTIVE COMPARATOR

Longitudinal ultrasound with the INFINITI phacomachine (Alcon Lab, USA)

Procedure: Longitudinal U/S (Infiniti system, Alcon, USA)

Longitudinal ultrasound (LEGACY)

ACTIVE COMPARATOR

Longitudinal ultrasound with the LEGACY phacomachine (Alcon Lab, USA)

Procedure: Longitudinal U/S (LEGACY 20000, Alcon, USA)

Interventions

Comparison of inta-operative efficacy and safety

Also known as: OZIL technology
Torsional ultrasound

comparison of efficacy and safety

Also known as: traditional ultrasound
Longitudinal ultrasound (INFINITI)

Interrupted energy modality

Also known as: Traditional U/S
Longitudinal ultrasound (LEGACY)

Eligibility Criteria

Age55 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients 55 years and older with a senile cataract grades 1 to 5 nuclear sclerosis based on Emery's classification,
  • endothelial cell density \> 1500 cells/mm2,
  • anterior chamber depth \> 2.4 mm, and
  • a dilated pupil \> 7 mm.

You may not qualify if:

  • eyes with pseudoexfoliation,
  • mature, traumatic, or complicated cataracts,
  • history of previous intra-ocular surgery, glaucoma, uveitis, and
  • patients who were unable to comply with follow-up examinations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Raghudeep eye clinic

Ahmedabad, Gujarat, 52, India

Location

Related Publications (1)

  • Liu Y, Zeng M, Liu X, Luo L, Yuan Z, Xia Y, Zeng Y. Torsional mode versus conventional ultrasound mode phacoemulsification: randomized comparative clinical study. J Cataract Refract Surg. 2007 Feb;33(2):287-92. doi: 10.1016/j.jcrs.2006.10.044.

MeSH Terms

Conditions

CataractIntraoperative Complications

Interventions

methylacetylene

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • shetal m raj, ms

    Iladevi Cataract and IOL Research Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 9, 2009

First Posted

November 10, 2009

Study Start

May 1, 2007

Primary Completion

December 1, 2008

Study Completion

March 1, 2009

Last Updated

November 13, 2009

Record last verified: 2009-11

Locations